N-[(Benzyloxy)carbonyl]-4-methyl-L-leucine - N-cyclohexylcyclohexanamine (1:1)(CAS: 88319-45-3)

The compound is subject to the European Union's REACH regulations, which require registration and reporting of substances based on their tonnage. It also falls under the scope of the U.S. EPA and FDA for safety and environmental considerations. GHS classification may include categories related to health and environmental hazards, requiring appropriate handling and disposal measures.

There are several alternatives, such as using isomers or analogs like N-[(Benzyloxy)carbonyl]-4-aminomethyl-L-leucine or similar amino acids, which can serve as viable substitutes depending on the specific requirements of the synthesis process. These alternatives can provide similar functionalities or properties with varying degrees of reactivity and selectivity.

The market for this compound is primarily driven by its use in pharmaceutical and biotechnological research due to its unique amino acid structure. Research trends focus on exploring its potential in drug development and as a chiral building block in synthesis. The compound's demand is likely to increase in niche markets requiring specific amino acid functionalities.

Waste containing the compound should be collected in appropriate containers and handled with care to prevent spills or leaks. Incineration is a common method for disposal, but professional waste disposal services should be used to ensure compliance with environmental regulations. It is crucial to follow local and national guidelines for hazardous waste management to protect the environment and human health.